Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.88 USD | +5.62% | +25.33% | -17.90% |
Business Summary
Number of employees: 23
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Treatments for Solid Tumor Cancers
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.35% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | -46.35% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
William Gray
DFI | Director of Finance/CFO | 36 | 16-01-31 |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Director/Board Member | 68 | 14-11-09 | |
Jaclyn Jaffe
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 68 | 14-11-09 | |
Michael Weiss
CHM | Chairman | 58 | 15-02-28 |
Christian Béchon
BRD | Director/Board Member | 63 | 18-10-15 |
Barry Salzman
BRD | Director/Board Member | 62 | 15-12-31 |
Neil Herskowitz
BRD | Director/Board Member | 67 | 15-07-31 |
James Oliviero
CEO | Chief Executive Officer | 48 | 15-10-12 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 700,000 | 0 | 0 | 90.63 % |
Stock B | 1 | 36,150,279 | 33,396,682 ( 92.38 %) | 0 |
Company contact information
Checkpoint Therapeutics, Inc.
95 Sawyer Road Suite 110
02453, Waltham
+781 652 4500
http://www.checkpointtx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.90% | 67.09M | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- CKPT Stock
- Company Checkpoint Therapeutics, Inc.